The rise of immuno-oncology, most recently CAR-T, represents a new generation of transformative cancer therapies offering hope for the patients of today and tomorrow. However, with this revolutionary approach to treating cancer, there are potential hurdles to patient access that must be acknowledged and overcome.

This session will focus on the transformative potential of CAR T as well as key challenges ahead for patients, providers, payers, and innovators. Topics will include: value and cost (to the patient and the healthcare system), coverage and reimbursement, and the potential for innovative payment arrangements.

Session ID: 54183